DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

HIV prevention is entering a new phase with the rise of innovative medications like the twice-yearly injectable lenacapavir.

The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the ...

The $400 million that the United States Congress removed from a list of programmes from which the Trump administration wants ...

Although Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...

Lenacapavir, a new HIV prevention injection, will offer six months of protection per dose at a cost of Sh6,000, according to ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

Yeztugo, a twice yearly injection, offers a promising advancement in HIV prevention, but high costs and insurance uncertainties may limit its accessibility.

Why a twice‑yearly injection might prove to be a good shot Lenacapavir is a first-in-class HIV drug that works by targeting ...

Congress removed from a list of programmes from which the Trump administration wants to cut funds, doesn't cancel the cuts to global HIV and TB programmes made in February . HIV projects that have ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...